Evoke Pharma Inc. | Mutual Funds
Mutual Funds that own Evoke Pharma Inc.
Vanguard Total Stock Market Index Fund
320,197
1.91%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
182,231
1.09%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
38,316
0.23%
0
0%
09/06/2018
iShares Micro Cap ETF
38,143
0.23%
0
0.01%
09/06/2018
Vanguard Institutional Total Stock Market Index Fund
27,238
0.16%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
15,864
0.1%
0
0%
07/31/2018
Fidelity Nasdaq Composite Index
7,184
0.04%
0
0%
07/31/2018
3,910
0.02%
0
0.04%
09/05/2018
Vanguard Total Stock Market Index Trust
3,475
0.02%
0
0%
07/31/2018
Vanguard Balanced Index Fund
3,400
0.02%
0
0%
07/31/2018
| Address |
420 Stevens Avenue
Solana Beach California 92075
United States
|
|
Employees
|
- |
| Website |
http://www.evokepharma.com |
| Updated |
07/08/2019 |
| Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. |
